BRPI0916228A2 - métodos e sistemas para avaliação de agentes de memória - Google Patents

métodos e sistemas para avaliação de agentes de memória

Info

Publication number
BRPI0916228A2
BRPI0916228A2 BRPI0916228A BRPI0916228A BRPI0916228A2 BR PI0916228 A2 BRPI0916228 A2 BR PI0916228A2 BR PI0916228 A BRPI0916228 A BR PI0916228A BR PI0916228 A BRPI0916228 A BR PI0916228A BR PI0916228 A2 BRPI0916228 A2 BR PI0916228A2
Authority
BR
Brazil
Prior art keywords
systems
methods
memory agents
evaluating memory
evaluating
Prior art date
Application number
BRPI0916228A
Other languages
English (en)
Inventor
Lila Davachi
Timothy Tully
Original Assignee
Dart Neuroscience Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dart Neuroscience Llc filed Critical Dart Neuroscience Llc
Publication of BRPI0916228A2 publication Critical patent/BRPI0916228A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/06—Methods of screening libraries by measuring effects on living organisms, tissues or cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
BRPI0916228A 2008-07-18 2009-07-17 métodos e sistemas para avaliação de agentes de memória BRPI0916228A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8194508P 2008-07-18 2008-07-18
PCT/US2009/051082 WO2010009453A1 (en) 2008-07-18 2009-07-17 Methods and systems for evaluating memory agents

Publications (1)

Publication Number Publication Date
BRPI0916228A2 true BRPI0916228A2 (pt) 2015-11-03

Family

ID=41550744

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0916228A BRPI0916228A2 (pt) 2008-07-18 2009-07-17 métodos e sistemas para avaliação de agentes de memória

Country Status (11)

Country Link
EP (1) EP2313098A4 (pt)
JP (1) JP5789511B2 (pt)
KR (1) KR20110049801A (pt)
CN (1) CN102143749A (pt)
AU (1) AU2009270697A1 (pt)
BR (1) BRPI0916228A2 (pt)
CA (1) CA2730940A1 (pt)
IL (1) IL210696A (pt)
MX (1) MX2011000652A (pt)
SG (1) SG195572A1 (pt)
WO (1) WO2010009453A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8277842B1 (en) 2012-01-20 2012-10-02 Dart Neuroscience (Cayman) Ltd. Enteric-coated HT-2157 compositions and methods of their use

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6770658B2 (en) * 1998-09-09 2004-08-03 Inflazyme Pharmaceuticals Ltd. Substituted γ-phenyl-Δ-lactams and uses related thereto
JP2002541440A (ja) * 1999-03-12 2002-12-03 ブラウン ユニバーシティ リサーチ ファウンデイション 記憶の固定を調節する方法及び組成物
ES2752800T3 (es) * 2000-05-01 2020-04-06 Cerecin Inc Uso de triglicéridos de cadena media para el tratamiento y la prevención de la enfermedad del Parkinson resultante de un metabolismo neuronal reducido
US8124589B2 (en) * 2000-05-01 2012-02-28 Accera, Inc. Use of ketogenic compounds for treatment of age-associated memory impairment
US20070179197A1 (en) * 2000-05-01 2007-08-02 Accera, Inc. Compositions and methods for improving or preserving brain function
JP2002020291A (ja) * 2000-06-30 2002-01-23 Sumitomo Pharmaceut Co Ltd 認知機能障害の治療剤
US7947731B2 (en) * 2000-08-10 2011-05-24 Cold Spring Harbor Laboratory Augmented cognitive training
US20040224316A1 (en) * 2000-08-10 2004-11-11 Tully Timothy P. Augmented cognitive training
ATE540047T1 (de) * 2002-06-25 2012-01-15 Helicon Therapeutics Inc Gedächtnisveränderung durch beeinflussung der funktion von staufen
US7642281B2 (en) * 2002-08-07 2010-01-05 Helicon Therapeutics, Inc. Indolone compounds useful to treat cognitive impairment
DK1540335T3 (da) * 2002-08-19 2010-07-26 Helicon Therapeutics Inc Screeningsfremgangsmåder til kognitive forstækere
HUE037129T2 (hu) * 2005-12-15 2018-08-28 Nestec Sa Kompozíciók és eljárások agyi funkció megõrzésére
EP2377533A3 (en) * 2006-05-19 2012-02-22 Helicon Therapeutics, Inc. Phosphodiesterase 4 inhibitors for cognitive and motor rehabilitation
GB0611458D0 (en) * 2006-06-09 2006-07-19 Univ Cambridge Tech Assessment of functional status
MX2008016083A (es) * 2006-06-26 2009-03-20 Helicon Therapeutics Inc Metodo para modular la excrecion de neuritas por el uso de un antagonista del receptor de galanina-3.

Also Published As

Publication number Publication date
MX2011000652A (es) 2011-06-16
KR20110049801A (ko) 2011-05-12
EP2313098A4 (en) 2011-12-21
WO2010009453A1 (en) 2010-01-21
AU2009270697A1 (en) 2010-01-21
IL210696A0 (en) 2011-03-31
SG195572A1 (en) 2013-12-30
CN102143749A (zh) 2011-08-03
EP2313098A1 (en) 2011-04-27
CA2730940A1 (en) 2010-01-21
JP2011528667A (ja) 2011-11-24
JP5789511B2 (ja) 2015-10-07
IL210696A (en) 2014-12-31

Similar Documents

Publication Publication Date Title
BRPI0910608A2 (pt) métodos e sistemas para avaliar resultados clínicos
BRPI0913924A2 (pt) métodos e sistemas para avaliação de infertilidade clínica
BRPI0820980A2 (pt) Composições e métodos para detecção de tiabs
BRPI0908379A2 (pt) sistemas e métodos para obter dentaduras customizadas
BRPI0717389A2 (pt) Dispositivos e métodos para avanço de stent
IS8948A (is) Aðferðir og kerfi fyrir einstaklingsbundnar aðgerðaráætlanir
BRPI0914034A2 (pt) dispositivo para limpeza de piso e método de limpeza de um piso
EP2106273A4 (en) SYSTEMS AND METHOD FOR INTRAOPERATIVE STIMULATION
BRPI1015922A2 (pt) sistemas e métodos para testar analitos
BRPI0907731A2 (pt) Câmara de detenção de plástico para escoamento de águas pluviais e sistemas e métodos relacionados
BRPI0813216A2 (pt) Inibidores de proteínas cinases e métodos para usá-los.
BRPI0910851A2 (pt) métodos e sistemas para protocolos de harq
BRPI0923760A2 (pt) artigos nanoestruturados e métodos para fabricação de artigos nanoestruturados
BRPI0818011A2 (pt) Método e dispositivo para associar objetos
BRPI0923159A2 (pt) gene de delta-endotoxina axmi-150 e métodos para sua utilização.
BRPI1010694A2 (pt) método e dispositivo para acessar o nó de retransmissão
BRPI0916492A2 (pt) dispositivo e método para detectar depósitos
BRPI0917905A2 (pt) dispositivo de memória e método do mesmo
BRPI0823036A2 (pt) Dispositivo de redução de ruído e método para redução de ruído
BRPI0809737A2 (pt) Método e sistema para medição de ph
BRPI0720604A2 (pt) Composição e método para detecção de desmineralização
BRPI0915492A2 (pt) sistemas e métodos para transferir valores
BRPI0919749A2 (pt) método para embalagem de cigarro e sistema de embalagem de cigarro
BRPI0917637A2 (pt) método, e, dispositivo de armazenamento de hardware
BRPI0907150A2 (pt) Dispositivo e método para microelastografia

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]